http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7721997-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f6fd8a92f55dca0f111bd7c5858ae83
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B64G1-62
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B64G1-22
filingDate 2007-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_845bcc4069528029c2a5ca43775ded0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0b6af884d756993af540a907ce8740d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5a3a67387e52f855b0bee473a0cb47a
publicationDate 2010-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7721997-B1
titleOfInvention Method and system for providing cruciform steered, bent biconic and plasma suppression for maximum accuracy
abstract A system for reducing plasma induced communication disruption utilizes an electrophilic gas injectant, bent reentry vehicle nose shaping and a number of flaps configured to provide 3-axis steering capability. Injecting electrophilic gas injectant into plasma accomplishes reduction of plasma induced communication disruption by removing free electrons in the plasma which causes the communication disruption. For reentry vehicles, a bent biconic nose also reduces plasma effect during reentry. By combining electrophilic gas injection and bent nose shaping, the system reduces and/or eliminates plasma induced communication disruption, such as, GPS communication blackout, for a reentry vehicle during reentry. Furthermore, the 3-axis steering capability renders the reentry vehicle more maneuverable. Performance of the reentry vehicle during reentry, such as, target accuracy, is thus improved.
priorityDate 2004-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4784350-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5789867-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6298289-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4961384-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3745928-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3392941-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3785591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002159215-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3883096-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6056237-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4014485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3114319-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129602314
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID190884
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517548
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID190884
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527022
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17358

Total number of triples: 33.